Company intelligence / Profile preview

IOT

Ownership: Private
Employees: ~95
Development stage: Commercial

Overview

IOT has developed and commercialized a suite of advanced ophthalmic lens technologies—including freeform progressive designs and light-adaptive photochromics—used in over 35 million lenses annually worldwide. Their platforms are widely adopted by independent optical labs for high-quality custom spectacle lenses. No clinical trial data in the pharmaceutical sense; performance validated through global adoption and wearer trials.

Therapeutic areas: Ophthalmology
Modalities: Device (ophthalmic lenses)Digital lens design technology (software-enabled)Photochromic lens technology (light activated lenses)Freeform lens design technology
Industry: Digital Health Medical Devices

Partnerships

Over **400 partners worldwide**, including independent optical labs such as Laramy-K

Beyond the preview

Go deeper on IOT.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IOT.

Explore the full profile